MURGF 0MSFT 0.74FNV.TO -4.09NVDA 8.18LLY -28.37CAT 14.02GL 0.27RY.TO 2.97
Metlife (MET)

NYSE:MET

Metlife (MET)

91.65
+0.50 (0.55%)
as of Jul 10, 2026, 8:00:00 pm Market Open.
36 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
Investor Insights
star iconJul 11, 2026, 12:00 am

This summary was created by AI, based on 1 opinions in the last 12 months.

Metlife (MET-N) has recently achieved a significant milestone by reaching a 52-week high, showcasing strong performance in the market. Experts highlight that the company is solid, conservative, and defensive in its investment strategies, which bodes well for investors looking for stability. The focus on conservative investments is viewed positively, as it helps minimize risk while ensuring steady returns. The emphasis on being invested in the right sectors indicates a strategic approach that aligns with long-term growth prospects. Overall, Metlife is seen as a reliable choice for those seeking a stable investment in today's fluctuating market environment.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
Prudential, PRU
BUY

Metlife(MET)

Jun 10, 2026

Just made a 52-week high. Solid, conservative and defensive, invested in the right things.

Photo of Jim Cramer - Mad MoneyJim Cramer - Mad MoneyUnlock Rating
$86.13

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
HOLD

Metlife(MET)

Jul 23, 2024

Higher rates are actually good for insurance companies. Yield is about 2.9%, growing at single digits and he prefers double-digit growth. The whole industry has a tailwind, and you can see it if you look at the KIE ETF.

Photo of David BurrowsDavid Burrows
No
Unlock Rating
$75.13

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
DON'T BUY

Metlife(MET)

Dec 01, 2023

Does not own shares. Financial services and insurance. Valuation is low and could be good time for investors. Does not own shares. Fundamentally a 6/10. Could be volatile. Better options out there for investors. 

Photo of Brianne GardnerBrianne GardnerUnlock Rating
$64.04

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK

Metlife(MET)

Mar 14, 2023
(A Top Pick Sep 27/22, Up 7.4%)Stockchase Research Editor: Michael O’Reilly

Our PAST TOP PICK with MET has triggered its stop at $65.  To remain disciplined, we recommend covering the position at this time.

Photo of The Panic-Proof Portfolio (Stockchase Research)The Panic-Proof Portfolio (Stockchase Research)
Unknown
Unlock Rating
$58.76

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK

Metlife(MET)

Nov 24, 2022
(A Top Pick Sep 27/22, Up 27.2%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with MET has achieved its target at $77. To remain disciplined, we recommend covering half the position and trailing up the stop loss (from $62) to $67. If triggered, this would result in a net investment gain of 18%.
Photo of The Panic-Proof Portfolio (Stockchase Research)The Panic-Proof Portfolio (Stockchase Research)
Unknown
Unlock Rating
N/A

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
HOLD

Metlife(MET)

Nov 23, 2022
Switch from Canadian insurers to MET? Hit a new high today. Likes it. Financials are at a historical discount. Likes banks, insurers and diversified financials. He wouldn't switch, as some Canadian valuations are quite cheap. Nice dividend of 2.6%.
Photo of Stan WongStan Wong
No
Unlock Rating
N/A

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
HOLD

Metlife(MET)

Nov 03, 2022
Model price of $87.26, 18% upside. Market really liked its write down on balance sheet or spinoff. Likes it here. Turned itself around. Will probably go to $80, and he'll evaluate it there.
Photo of Brian Acker, CABrian Acker, CAUnlock Rating
$72.71

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK

Metlife(MET)

Nov 01, 2022
(A Top Pick Sep 27/22, Up 22.4%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with MET is progressing well. To remain disciplined, we now recommend trailing up the stop (from $52.50) to $62.00.
Photo of The Panic-Proof Portfolio (Stockchase Research)The Panic-Proof Portfolio (Stockchase Research)
Unknown
Unlock Rating
$74.04

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK

Metlife(MET)

Sep 27, 2022
Stockchase Research Editor: Michael O'Reilly This world leader in insurance and benefits is a TOP PICK. The company just announced a deal along with PRU to assume the $16 billion pension obligation of IBM -- right up its alley. We like the value here as the company is trading under book value, just beat analyst earnings expectations, and is projected to trade 7x earnings. It has managed to increase cash reserves, while aggressively retiring debt and buying back shares. Its dividend is backed by a payout ratio under 50% of cash flow. We recommend placing a stop loss at $52.50, looking to achieve $77 -- upside potential of 25%. Yield 3.2% (Analysts’ price target is $77.25)
Photo of The Panic-Proof Portfolio (Stockchase Research)The Panic-Proof Portfolio (Stockchase Research)
Unknown
Unlock Rating
$60.49

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
BUY

Metlife(MET)

Jun 16, 2021
The insurers have been in fire, like MetLife. He believes rates will go higher, so definitely stick with them.
Photo of Guy AdamiGuy AdamiUnlock Rating
$63.71

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
DON'T BUY

Metlife(MET)

Sep 23, 2020
It's fine, but he does not likes financials (or energy). He just likes MET's yield and that's it.
Photo of Jim Cramer - Mad MoneyJim Cramer - Mad MoneyUnlock Rating
$36.09

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
COMMENT

Metlife(MET)

Jan 30, 2020

AIG-N vs. MET-N. AIG-N has been recapitalizing since the disaster of the financial crisis. MET-N did not suffer these issues. The life business is in pretty decent shape but he prefers Canadian lifecos. (Analysts’ price target is $55.57)

Photo of Lorne SteinbergLorne SteinbergUnlock Rating
$51.28

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
BUY

Metlife(MET)

Sep 20, 2019
It’s pretty cheap, trading at 8.1 times. Their earnings in July were double year over year and beat expectations. They are growing globally and it’s a safe name with a low valuation. Couldn’t go wrong with this choice in the long term.
Photo of Greg NewmanGreg NewmanUnlock Rating
$47.44

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
WAIT

Metlife(MET)

Aug 08, 2019
MET vs. BAC. Dynamics of the two are different, so hard to compare. FMV potential of both is huge. But the market won't go, because interest rates are falling. Aren't any drivers to escalate earnings. Very cheap, but who knows when they're going to pop? (Analysts’ price target is $53.19)
Photo of Ross HealyRoss HealyUnlock Rating
$47.17

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
DON'T BUY

Metlife(MET)

Jun 14, 2019
The balance sheet is impaired and there should be write-offs, which he hasn't seen. He sees 32% upside with a $64 model price, but he'd be happy seeing this at $53.80. He would recommend this stock above this price. He has recommended MET before, but MET just can't get going. The balance sheet is ugly. Also, if interest rates fall to zero, all insurance companies will get hit.
Photo of Brian Acker, CABrian Acker, CA
Owned
Unlock Rating
$48.81

Stock price when the opinion was issued

$91.65

As of Jul 10, 2026. Market Open.

insurance
Showing 1 to 15 of 112 entries

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

FTAI -0.67$227.35
UNH -7.06$424.62
DKS 0.66$217.98
META 37.73$669.21
MAR 3.64$376.11
The ultimate 360° Tracker Your financial life in one place, automaticallywealthica-video

Today's Top Picks

MURGF 0$574.99
MSFT 0.74$385.1
FNV.TO -4.09$290.92
NVDA 8.18$210.96
LLY -28.37$1188.58

Popular Articles

Latest Sell Signals

MU -12.34$979.3
MU -12.34$979.3
GDX -0.25$75.53
CAG 0.46$13.83
PEP -0.48$137.38

Most Recent Experts

Stephen Weiss, Founder, Short Hills Capital Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Jenny Harrington, CEO, Gilman Hill Asset Management

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Kevin Simpson

Capital Wealth Planning

Bill Baruch, Founder, Blue Line Capital

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Darren Sissons

Darren Sissons

Campbell Lee & Ross

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica

Metlife (MET) Frequently Asked Questions

What is Metlife stock symbol?

Metlife is a American stock, trading under the symbol MET (previously MET-N on Stockchase) on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET

Is Metlife a buy or a sell?

In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MET (previously MET-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Metlife.

Is Metlife a good investment or a top pick?

Metlife was recommended as a Top Pick by Brian Acker, CA on 2019-06-14. Read the latest stock experts ratings for Metlife.

Why is Metlife stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Metlife.

Is Metlife worth watching?

Metlife is followed by 36 investors on Stockchase and is a trending stock that is worth watching.

What is Metlife stock price?

On 2026-07-10, Metlife (MET) stock closed at a price of $91.65.

You may also like